These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1836986)

  • 1. Dose-finding study of cilazapril (Inhibace) in patients with uncomplicated essential hypertension.
    Mroczek WJ; Klein J; Burris JF
    Clin Exp Hypertens A; 1991; 13(8):1415-32. PubMed ID: 1836986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension.
    Kobrin I; Güntzel P; Viskoper R; Paran E; Zimlichman R
    Drugs; 1991; 41 Suppl 1():31-6. PubMed ID: 1712270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study.
    Kobrin I; Ben-Ishay D; Bompani R; Dixon R; Hoverman RJ; Jones RW; Kögler P; Sanchez R
    Am J Med; 1989 Dec; 87(6B):33S-36S. PubMed ID: 2532458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients.
    Güntzel P; Kobrin I; Pasquier C; Zimlichman R; Viskoper JR
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):8-12. PubMed ID: 1708060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG; Bolli P; Lee C
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of cilazapril, 2.5 and 5 mg, once daily versus placebo on ambulatory blood pressure following single- and repeat-dose administration.
    Lacourcière Y; Poirier L; Provencher P; Pyzyk M
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):219-23. PubMed ID: 1717782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilazapril: an overview of its efficacy and safety in hypertension.
    Szucs T; Schneeweiss A
    Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension.
    Belz GG; Breithaupt K; Erb K; Kleinbloesem CH; Wolf GK
    J Hypertens; 1989 Oct; 7(10):817-24. PubMed ID: 2531184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
    White WB; McCabe EJ; Hager WD; Schulman P
    Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of 2.5 and 5 mg cilazapril versus placebo on daily blood pressure load.
    Poirier L; Pyzyk M; Provencher P; Lacourcière Y
    Am J Hypertens; 1991 Nov; 4(11):913-5. PubMed ID: 1838693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension.
    Kögler P
    Am J Med; 1989 Dec; 87(6B):50S-55S. PubMed ID: 2532461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
    Rosendorff C; Patton J; Radford HM; Kalliatakis B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S105-9. PubMed ID: 1382157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group.
    Morgan TO
    Am J Med; 1989 Dec; 87(6B):37S-41S. PubMed ID: 2532459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of cilazapril in hypertensive patients with moderate to severe renal impairment.
    Carlsen JE; Hansen FM; Jensen HA
    Am J Med; 1989 Dec; 87(6B):79S-82S. PubMed ID: 2532466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.
    Fernandez PG; Bolli P; Lee C; Vasdev S
    Can J Cardiol; 1990; 6(1):9-14. PubMed ID: 2138049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of cilazapril improves diastolic function in hypertensive patients.
    Marmor A; Green T; Krakuer J; Szucs T; Schneeweiss A
    Am J Med; 1989 Dec; 87(6B):61S-63S. PubMed ID: 2532463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of cilazapril, a new angiotensin-converting enzyme inhibitor.
    Goldszer RC; Rodriguez R; Solomon HS
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):300S-302S. PubMed ID: 2970856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.